Latest News and Press Releases
Want to stay updated on the latest news?
-
WASHINGTON, DC--(Marketwire - January 8, 2008) - Q-Industries, a developer of websites and business applications, has completed the website for DeepMile Networks, which provides niche business...
-
buch.de internetstores AG / Preliminary announcement on the disclosure of financial statements 08.01.2008 Announcement according to articles 37v, 37w, 37x ff....
-
MTG: 2008 FINANCIAL CALENDAR Modern Times Group MTG AB (publ.) (‘MTG' or ‘the Group'), the international entertainment broadcasting group, today announced the preliminary dates for the publication of...
-
MTG: KALENDARIUM 2008 Den internationella mediekoncernen Modern Times Group MTG AB (publ.) ('MTG' eller 'Koncernen'), tillkännagav idag följande preliminära datum för delårsrapporter samt...
-
TFG Capital AG Unternehmensbeteiligungsgesellschaft / Miscellaneous 08.01.2008 Release of a Corporate-announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely...
-
On behalf of Mare Baltic PCC Limited, the issuer of the above notes, listed on the OMX Copenhagen Stock Exchange, HSH Nordbank Copenhagen Branch, in its capacity of Listing Agent to Mare Baltic PCC...
-
On behalf of Mare Baltic PCC Limited, the issuer of the above notes, listed on the OMX Copenhagen Stock Exchange, HSH Nordbank Copenhagen Branch, in its capacity of Listing Agent to Mare Baltic PCC...
-
First North: Nordic Service Partners Holding AB will move from First North to the Main Market (5/08)At the request of Nordic Service Partners Holding AB, trading in Nordic Service Partners Holding AB series B shares is to cease on First North. As from January 15, Nordic Service Partners Holding will...
-
LAS VEGAS, Jan. 8, 2008 (PRIME NEWSWIRE) -- MetaPower International, Inc. (Pink Sheets:MTPW) is pleased to announce that the Company's subsidiary, MetaPower Canada, has received purchase orders...
-
MORRIS PLAINS, N.J., Jan. 8, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious...